ResMed Inc. (NYSE:RMD) completed a two-for-one split of the company’s stock on August 30, doubling the number of its outstanding shares of common stock.
The San Diego-based sleep apnea device maker’s number of shares now stands at about 151.4 million, excluding those held as treasury stock, according to the company.
ResMed’s stock closed at $60.38 on the day of the split, indicating a new price of $30.19 per share. The company’s total market capitalization was approximately $4.6 billion on that date.
